Moringin, an isothiocyanate modulates multiple cellular signalling molecules in breast cancer cells.
Apoptosis
Breast cancer
Inflammation
Isothiocyanate
Long non-coding RNA
Moringin
Prohibitin
Journal
Cellular signalling
ISSN: 1873-3913
Titre abrégé: Cell Signal
Pays: England
ID NLM: 8904683
Informations de publication
Date de publication:
19 Apr 2024
19 Apr 2024
Historique:
received:
28
11
2023
revised:
27
03
2024
accepted:
14
04
2024
medline:
22
4
2024
pubmed:
22
4
2024
entrez:
21
4
2024
Statut:
aheadofprint
Résumé
Prohibitin (PHB) is a pleiotropic molecule with a variety of known functions and subcellular locations. PHB's function in breast cancer is poorly understood. Herein, we report that PHB is expressed in cancer types of diverse origin including breast cancer. The cancer patients with changes in PHB were reported to have significantly reduced 'overall survival' in comparison to the cases without alterations in PHB. The expression of PHB was increased by H
Identifiants
pubmed: 38643946
pii: S0898-6568(24)00149-9
doi: 10.1016/j.cellsig.2024.111181
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
111181Informations de copyright
Copyright © 2024. Published by Elsevier Inc.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare that they have no competing interests.